Tracy Liu - Nov 20, 2023 Form 4 Insider Report for ACM Research, Inc. (ACMR)

Role
Director
Signature
/s/ Mark McKechnie, Attorney-in-Fact for Tracy Liu
Stock symbol
ACMR
Transactions as of
Nov 20, 2023
Transactions value $
-$158,250
Form type
4
Date filed
11/22/2023, 04:15 PM
Previous filing
Aug 21, 2023
Next filing
Dec 28, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ACMR Class A Common Stock Options Exercise $110K +15K +40.62% $7.36 51.9K Nov 20, 2023 Direct F1
transaction ACMR Class A Common Stock Sale -$269K -15K -28.89% $17.91 36.9K Nov 20, 2023 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ACMR Stock Option Options Exercise $0 -15K -100% $0.00* 0 Nov 20, 2023 Class A Common Stock 15K $7.36 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 On November 20, 2023, the reporting person exercised a previously issued stock option to purchase 15,000 shares of Class A Common Stock of the Issuer.
F2 The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 21, 2023.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.68 to $18.09, inclusive.
F4 The option is fully vested and exercisable.